Related Experiment Video
Updated: Jul 15, 2026
05:51
A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia
Published on: June 15, 2011
Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis
1Department of Biomathematics, University of Thessaly School of Medicine, Larissa, Greece. zintza@med.uth.gr
Psychiatric Genetics
|April 7, 2007
Summary
This meta-analysis found no association between the brain-derived neurotrophic factor G196A polymorphism and schizophrenia risk. However, the C270T polymorphism showed a weak association, warranting further investigation.
Area of Science:
- Neuroscience
- Genetics
- Psychiatry
Background:
- Schizophrenia is a complex psychiatric disorder with a significant genetic component.
- Brain-derived neurotrophic factor (BDNF) plays a crucial role in neuronal development and function, making its gene a candidate for schizophrenia susceptibility.
- Genetic variations, such as polymorphisms, in the BDNF gene may influence schizophrenia risk.
Purpose of the Study:
- To investigate the association between two specific BDNF gene polymorphisms, G196A and C270T, and the risk of developing schizophrenia.
- To conduct a meta-analysis of existing genetic association studies to consolidate findings and improve statistical power.
Main Methods:
- A meta-analysis was performed on nine genetic association studies.
- Genotype data from 1404 schizophrenic patients and 1597 controls for the G196A polymorphism were analyzed.
- Genotype data from 877 schizophrenic patients and 989 controls for the C270T polymorphism were analyzed.
Main Results:
- The G196A polymorphism showed no significant association with schizophrenia risk, despite some heterogeneity between studies.
- A trend towards heterogeneity was observed in Caucasian populations for G196A.
- The C270T polymorphism demonstrated a significant association with an increased risk of schizophrenia (odds ratio 1.63), particularly in the dominant model (odds ratio 1.68), with significant heterogeneity present.
Conclusions:
- The meta-analysis provides weak evidence for an association between the BDNF C270T polymorphism and schizophrenia.
- No evidence of association was found for the BDNF G196A polymorphism.
- The significant heterogeneity observed underscores the need for larger, more robust genetic association studies to confirm these findings.
Related Concept Videos
01:29Biological Causes of Schizophrenia
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin studies.
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within the...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
01:29Psychological and Sociocultural Causes of Schizophrenia
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
01:05Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...